UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
批准号:
10793918
负责人:
KENNETH E PALMER
金额:
$293.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-18 至 2028-07-31
关键词:
AttentionBiological WarfareBiomedical ResearchBiotechnologyCOVID-19COVID-19 pandemicCOVID-19 patientChinaClinical TrialsCommunitiesContainmentCreativenessCrownsDedicationsDiagnosticDisease OutbreaksEconomicsEmerging Communicable DiseasesEnsureFederal GovernmentFunding OpportunitiesFutureGoalsHealth Services ResearchHealth care facilityHospitalsHourHuman ResourcesIndustryInfectionInstitutionInternationalInvestigational New Drug ApplicationKentuckyLaboratoriesLeadershipLearningMaintenanceManaged CareMedicineMentorsMissionModelingNational Center for Advancing Translational SciencesNational Institute of Diabetes and Digestive and Kidney DiseasesNosePatientsPhilosophyPlayPublic HealthResearchResearch PersonnelResearch SupportResourcesRestReverse Transcriptase Polymerase Chain ReactionRiskRoleScientistSerology testServicesSystemTalentsTechniquesTestingTherapeuticTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesUniversity resourcesVaccinesWorkWorkforce Developmentbiocontainment facilitybiodefensebiothreatcohortemergency preparednessexperienceimprovedlaboratory experiencemedical countermeasuremetropolitannovelnovel coronavirusoperationpandemic diseasepandemic preparednesspandemic responsepathogenprevious pandemicprognosticprophylacticpublic health emergencyrecruitresponseservice organizationskillswastewater surveillance
中文摘要
总结(整体):
英文摘要
SUMMARY (OVERALL):
The University of Louisville Regional Biocontainment Laboratory (RBL) is operated by the University Center for
Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM). The RBL is a regional resource
that facilitates translational research to develop diagnostics, prognostics, therapeutics and vaccines to mitigate
biodefense and emerging infectious disease threats. Our Center operates the only BSL-3 and ABSL-3 facilities
currently operating in the Commonwealth of Kentucky. The CPM mandate is to prepare for and respond to public
health emergencies, such as the COVID-19 pandemic.
The broad, long-range objectives and goals of the University of Louisville (UofL) CPM RBL are:
1. To offer state-of-the-art research services to the regional and national biomedical research community to
learn from past pandemics and biological warfare experiences and effectively predict and mitigate future
emerging infectious disease threats.
2. To manage, maintain and operate the UofL RBL to serve the national and regional need for biocontainment
facilities suitable for research on Risk Group 3 pathogens and other biothreats.
3. To follow a philosophy of continuous improvement in BSL-3 and ABSL-3 work practices and to ensure that
all personnel who need to access BSL-3 and ABSL-3 containment laboratories are appropriately trained and
prepared to serve the national and regional need for biocontainment research professionals.
To achieve these aims we propose to establish three collaborative Cores. The Facilities Management
Maintenance and Operations Core (FMMO Core) is responsible for ensuring that the facility is always available
to meet the research and emergency preparedness mission of the RBL. The BSL-3 Practices and Workforce
Development Core (BSL-3PWD Core) formalizes our mentor-mentee training plan to ensure our laboratory is
staffed with BSL-3 research professionals who are proficient at biocontainment research professionals. This core
responds to the reality that response to rapidly emerging public health emergencies like COVID-19 is limited by
the number of available BSL-3 trained and experienced research professionals. Our Pandemic Preparedness
and Response Integrated Research Core (PaPR Core) responds to the substantially increased requests for our
BSL-3 research services by organizing an integrated full-service BSL-3 research support function to support
investigator needs. These cores will work in unison to achieve the CPM mission: to prepare for and respond to
public health emergencies like the COVID-19 pandemic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UofL RBL Pandemic Preparedness and Response Integrated Research Core
-
批准号:10793921
-
项目类别:
-
资助金额:$179.3万
-
财政年份:2023
-
负责人:KENNETH E PALMER
-
依托单位:
Upgrading infectious disease research facilities at University of Louisville RBL
-
批准号:10631406
-
项目类别:
-
资助金额:$121.97万
-
财政年份:2022
-
负责人:KENNETH E PALMER
-
依托单位:
Upgrading infectious disease research facilities at University of Louisville RBL
-
批准号:10394525
-
项目类别:
-
资助金额:$333.33万
-
财政年份:2021
-
负责人:KENNETH E PALMER
-
依托单位:
Project 2: PREVENT Preclinical safety and efficacy studies
-
批准号:9276592
-
项目类别:
-
资助金额:$12.8万
-
财政年份:2016
-
负责人:KENNETH E PALMER
-
依托单位:
Project 2: PREVENT Preclinical safety and efficacy studies
-
批准号:8769379
-
项目类别:
-
资助金额:$58.76万
-
财政年份:2014
-
负责人:KENNETH E PALMER
-
依托单位:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
-
批准号:8769373
-
项目类别:
-
资助金额:$363.9万
-
财政年份:2014
-
负责人:KENNETH E PALMER
-
依托单位:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
-
批准号:9095157
-
项目类别:
-
资助金额:$324.81万
-
财政年份:2014
-
负责人:KENNETH E PALMER
-
依托单位:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
-
批准号:8875600
-
项目类别:
-
资助金额:$331.75万
-
财政年份:2014
-
负责人:KENNETH E PALMER
-
依托单位:
Antiviral lectins as microbicides
-
批准号:7795249
-
项目类别:
-
资助金额:$52.59万
-
财政年份:2008
-
负责人:KENNETH E PALMER
-
依托单位:
Antiviral lectins as microbicides
-
批准号:8056628
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2008
-
负责人:KENNETH E PALMER
-
依托单位:
Antiviral lectins as microbicides
-
批准号:7609205
-
项目类别:
-
资助金额:$96.67万
-
财政年份:2008
-
负责人:KENNETH E PALMER
-
依托单位:
Antiviral lectins as microbicides
-
批准号:7494269
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2008
-
负责人:KENNETH E PALMER
-
依托单位:
Display of HIV-1 Epitopes on Plant Virus Particles
-
批准号:6800114
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:KENNETH E PALMER
-
依托单位:
Display of HIV-1 Epitopes on Plant Virus Particles
-
批准号:6656150
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:KENNETH E PALMER
-
依托单位:
Project 2: PREVENT Preclinical safety and efficacy studies
-
批准号:9095166
-
项目类别:
-
资助金额:$31.01万
-
财政年份:--
-
负责人:KENNETH E PALMER
-
依托单位:
Core A: PREVENT Program Administrative Core
-
批准号:9276574
-
项目类别:
-
资助金额:$12.44万
-
财政年份:--
-
负责人:KENNETH E PALMER
-
依托单位:
Core A: PREVENT Program Administrative Core
-
批准号:8875601
-
项目类别:
-
资助金额:$33.74万
-
财政年份:--
-
负责人:KENNETH E PALMER
-
依托单位:
Core A: PREVENT Program Administrative Core
-
批准号:8769374
-
项目类别:
-
资助金额:$34.17万
-
财政年份:--
-
负责人:KENNETH E PALMER
-
依托单位:
海外基金